Sphera Funds Management’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Sphera Funds Management's PALI Position: Q3 2026 in Review
Sphera Funds Management increased its Palisade Bio (PALI) stake by 9.2% in Q3 2026, buying an estimated $404K and bringing the position to 2,464,038 shares worth $3.33M. The position accounts for 0.47% of the portfolio, ranked #74.
Sphera Funds Management first reported a position in PALI in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.72M in Q2 2026. 114 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Sphera Funds Management held 2,464,038 shares of Palisade Bio worth $3.33M as of Q3 2026.
- Sphera Funds Management bought 206,932 Palisade Bio shares in Q3 2026, an estimated $404K.
- Palisade Bio made up 0.47% of Sphera Funds Management's portfolio in Q3 2026, its #74 holding.
- Sphera Funds Management first reported a position in Palisade Bio in Q4 2025 and has held it in 4 quarters since.
- Sphera Funds Management's Palisade Bio position peaked at $4.72M in Q2 2026.
- 114 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Sphera Funds Management's 13F filing for Q3 2026, filed 16 Nov 2026.